These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2572405)

  • 1. [Assay of NK cell activity and IL-2 and IFNr production in vitro in patients with epidemic hemorrhagic fever].
    Gao Q; Wang XH
    Zhonghua Nei Ke Za Zhi; 1989 Mar; 28(3):150-2, 186. PubMed ID: 2572405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modulation effect of lithium on IL-2 and IFNr production by human peripheral blood mononuclear cells].
    Wu YY
    Zhonghua Zhong Liu Za Zhi; 1992 Sep; 14(5):337-9. PubMed ID: 1337888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia.
    Tajima F; Kawatani T; Endo A; Kawasaki H
    Leukemia; 1996 Mar; 10(3):478-82. PubMed ID: 8642865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic observations on NK cell activity and IL-2 and IFN gamma production in vitro in patients on maintenance hemodialysis.
    Dai Y; Yu Y; Tang SC; Cai TY; Li D
    J Tongji Med Univ; 1993; 13(4):221-5. PubMed ID: 8151741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro modulation of natural killer activity of human peripheral blood mononuclear cells against prostate tumor cell line.
    Sheikhi A; Saadati K; Salmani R; Yahaghi N; Sheikhi A; Siemens DR
    Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):700-8. PubMed ID: 21425925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natural killer (NK) cells and interleukin 2 (IL-2) in Crohn disease].
    Lozano Polo JL; Echevarría Vierna S; Casafont Morencos F; Ledesma Castaño F; Pons Romero F
    Rev Esp Enferm Dig; 1990 Aug; 78(2):71-5. PubMed ID: 2271297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
    Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
    Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of IL-18 receptor in cancer patients: its clinical significance.
    Kobashi K; Iwagaki H; Yoshino T; Morimoto Y; Kohka H; Kodama M; Nishibori M; Akagi T; Tanaka N
    Anticancer Res; 2001; 21(5):3285-93. PubMed ID: 11848485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells.
    Pintaric M; Gerner W; Saalmüller A
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):68-82. PubMed ID: 17913242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake.
    Laso FJ; Lapeña P; Madruga JI; San Miguel JF; Orfao A; Iglesias MC; Alvarez-Mon M
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1226-31. PubMed ID: 9347083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of recombinant human interferon-gamma and interleukin 2 on natural killer cell activity of peripheral blood in early human development.
    Ueno Y; Miyawaki T; Seki H; Matsuda A; Taga K; Sato H; Taniguchi N
    J Immunol; 1985 Jul; 135(1):180-4. PubMed ID: 3923100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-21 increases direct cytotoxicity and IFN-γ production of ex vivo expanded NK cells towards breast cancer cells.
    Park YK; Shin DJ; Cho D; Kim SK; Lee JJ; Shin MG; Ryang DW; Lee JS; Park MH; Yoon JH; Jegal YJ
    Anticancer Res; 2012 Mar; 32(3):839-46. PubMed ID: 22399602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of human CD56+ cell cytotoxicity and IFN-gamma production.
    Derby EG; Reddy V; Nelson EL; Kopp WC; Baseler MW; Dawson JR; Malyguine AM
    Cytokine; 2001 Jan; 13(2):85-90. PubMed ID: 11145847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kinetic observation on BRC immune function of patients with epidemic hemorrhagic fever].
    Kang Y; Wang WY; Zhao WQ
    Zhonghua Nei Ke Za Zhi; 1991 Jun; 30(6):357-9, 383. PubMed ID: 1680614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients.
    Zerhouni B; Sanhadji K; Kehrli L; Livrozet JM; Touraine JL
    Thymus; 1997; 24(3):147-56. PubMed ID: 9151380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-18 restores immune suppression in patients with nonseptic surgery, but not with sepsis.
    Hiraki S; Ono S; Kinoshita M; Tsujimoto H; Seki S; Mochizuki H
    Am J Surg; 2007 Jun; 193(6):676-80. PubMed ID: 17512275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells.
    Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL
    Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of whole body hyperthermia on the immune cell activity of cancer patients.
    Park MM; Hornback NB; Endres S; Dinarello CA
    Lymphokine Res; 1990; 9(2):213-23. PubMed ID: 2110991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.